查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1429266

石材遷移防止裝置市場：現況分析與預測（2023-2030）

Anti-retropulsion Devices Market: Current Analysis and Forecast (2023-2030)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 144 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計2023年至2030年，石材遷移防止裝置市場的複合年增長率約為5.2%。預防結石遷移設備市場是指醫療設備產業的一部分，專注於設計在內視鏡手術期間防止結石遷移的設備，特別是在泌尿外科領域。這些設備在輸尿管鏡檢查等手術過程中使用，透過最大限度地降低結石返回腎臟或泌尿道其他部位的風險來提高結石清除的有效性和安全性。全球泌尿系結石的發生率和盛行率不斷上升，增加了對有效和微創治療方案的需求，這促進了泌尿內視鏡手術中防結石遷移裝置的採用。我是。例如，根據 NCBI 的數據，2019 年，全球發生了 11,55,52,140 例尿路結石病例，6,04,308.9 例估算 DALY，13,278.9 例死亡。此外，泌尿系結石預防設備技術的持續創新和進步，例如開發具有增強的可操作性、靈活性以及與內視鏡設備相容性的設備，正在推動市場成長。

根據最終用戶，市場分為醫院、門診手術中心等。在預測期內，醫院預計將更多地採用石頭遷移預防設備。醫院因泌尿系統疾病（包括尿石症）而住院的人數急劇增加，並且需要在尿內視鏡手術中使用防結石遷移裝置以優化患者的治療效果。此外，醫院還配備了先進的基礎設施、最先進的內視鏡設備和專業設施，有助於在微創泌尿外科手術中有效使用防結石遷移裝置。此外，醫院通常擁有專門的泌尿外科部門和具有泌尿治療專業知識的熟練醫療專業人員，促進了防結石遷移設備在泌尿外科治療途徑中的採用和整合。

為了更了解石材向後遷移防止裝置產業的市場實施情況，將市場分為北美（美國、加拿大、北美其他地區）、歐洲（德國、英國、法國、西班牙、義大利、歐洲其他地區） 、亞太地區（中國、日本、印度等亞太地區）以及世界其他地區。北美結石遷移預防裝置市場的推動因素包括尿石症盛行率的不斷上升、醫療保健專業人員和一般大眾對結石遷移預防裝置的認識不斷提高、培訓和教育市場的發展以及醫療成本的上升。是期待。例如，根據 census.gov 的數據，2020 年老年人口將增加 5,090 萬人，從 1920 年的 490 萬人（占美國總人口的 4.7%）增加到 5,580 萬人（占美國總人口的 16.8%）。

目錄

第一章 市場介紹

  • 市場定義
  • 主要目標
  • 利益相關者
  • 限制

第二章 研究方法或假設

  • 調查過程
  • 調查方法
  • 受訪者簡介

第三章市場總結

第 4 章執行摘要

第五章 COVID-19 對石材遷移防止裝置市場的影響

第六章 2020-2030年全球石材後移防止裝置市場收入

第 7 章 最終用戶的市場洞察

  • 醫院
  • 門診手術中心
  • 其他

第八章按地區劃分的市場洞察

  • 北美石材遷移防止裝置市場
    • 美國
    • 加拿大
    • 其他北美
  • 歐洲石材遷移防止裝置市場
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區石材遷移防止裝置市場
    • 中國
    • 日本
    • 印度
    • 亞太其他地區
  • 其他地區石材遷移防止裝置市場

第九章石材逆流防止裝置市場動態

  • 市場驅動力
  • 市場挑戰
  • 影響分析

第十章石材後移防止裝置市場機會

第十一章石材後移防止裝置市場趨勢與見解

第十二章需求側和供給面分析

  • 需求面分析
  • 供給側分析

第十三章價值鏈分析

第14章價格分析

第15章 競爭場景

  • 競爭格局
    • 波特五力分析

第十六章公司簡介

  • Accordion Medical
  • AstraZeneca pharma
  • Boston Scientific Corporation
  • Cook
  • Teleflex Incorporated
  • NIKSAN PHARMACEUTICAL
  • AdvaCare Pharma
  • Omicron Pharma
  • Cadila Pharmaceutical
  • ORFE MEDICAL

第十七章 免責聲明

簡介目錄
Product Code: UMHE212560

The anti-retropulsion devices market is expected to register a CAGR of approx. 5.2% over the period of 2023-2030. The antiretropulsion device market refers to the segment of the medical device industry focused on devices designed to prevent stone migration during endoscopic procedures, particularly in the field of urology. These devices are utilized during procedures such as ureteroscopy to enhance the efficacy and safety of stone removal by minimizing the risk of stone migration back into the kidney or other parts of the urinary tract. The rising incidence and prevalence of urolithiasis (urinary tract stones) globally have heightened the demand for effective and minimally invasive treatment options, thereby driving the adoption of antiretropulsion devices in endourological procedures. For instance, according to the NCBI, In 2019, 11,55,52,140 incident cases of urolithiasis with 6,04,308.9 attributed DALYs and 13,278.9 deaths occurred globally. Furthermore, Continuous innovation and advancements in antiretropulsion device technology, including the development of devices with enhanced maneuverability, flexibility, and compatibility with endoscopic equipment, are driving market growth.

Based on the end-user, the market has been categorized into hospitals, ambulatory surgical centers, others. Among them, the hospital category is to witness higher adoption of anti-retropulsion devices during the forecast period. The hospitals are witnessing a surge in admissions for urological disorders, including urinary tract stones, necessitating the utilization of antiretropulsion devices in endourological procedures to optimize patient outcomes. Moreover, hospitals are equipped with advanced infrastructure, state-of-the-art endoscopic equipment, and specialized facilities that facilitate the effective utilization of antiretropulsion devices in minimally invasive urological procedures. Furthermore, hospitals often have specialized urology departments and skilled healthcare professionals proficient in endourological interventions, thereby fostering the adoption and integration of antiretropulsion devices in urological care pathways.

For a better understanding of the market adoption of the anti-retropulsion devices industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. The North America Anti-retropulsion Devices market is expected to continue to grow in the coming years, driven by the increasing prevalence of urolithiasis and growing awareness of anti-retropulsion devices among healthcare professionals and the general population, development of training and education and the rise in healthcare expenditure. For instance, in 2020, according to census.gov, The older population increased by 50.9 million, from 4.9 million (or 4.7% of the total U.S. population) in 1920 to 55.8 million (16.8%) in 2020.

Some of the major players operating in the market include Accordion Medical, AstraZeneca pharma, Boston cientific Corporation, Cook, Teleflex Incorporated, NIKSAN PHARMACEUTICAL, AdvaCare Pharma, Omicron Pharma, Cadila Pharmaceutical, ORFE MEDICAL.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Anti-retropulsion Devices Market
  • 2.2. Research Methodology of the Anti-retropulsion Devices Market
  • 2.4. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE ANTI-RETROPULSION DEVICES MARKET

6 GLOBAL ANTI-RETROPULSION DEVICES MARKET REVENUE, 2020-2030F

7 MARKET INSIGHTS BY END-USERS

  • 7.1. Hospitals
  • 7.2. Ambulatory surgical centers
  • 7.3. Others

8 MARKET INSIGHTS BY REGION

  • 8.1 NORTH AMERICA ANTI-RETROPULSION DEVICES MARKET
    • 8.1.1. U.S.
    • 8.1.2. Canada
    • 8.1.3. Rest of North America
  • 8.2 EUROPE ANTI-RETROPULSION DEVICES MARKET
    • 8.2.1. Germany
    • 8.2.2. U.K.
    • 8.2.3. France
    • 8.2.4. Italy
    • 8.2.5. Spain
    • 8.2.6. Rest of Europe
  • 8.3 ASIA PACIFIC ANTI-RETROPULSION DEVICES MARKET
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. India
    • 8.3.4. Rest of Asia-Pacific
  • 8.4 REST OF THE WORLD ANTI-RETROPULSION DEVICES MARKET

9 ANTI-RETROPULSION DEVICES MARKET DYNAMICS

  • 9.1. Market Drivers
  • 9.2. Market Challenges
  • 9.3. Impact Analysis

10 ANTI-RETROPULSION DEVICES MARKET OPPORTUNITIES

11 ANTI-RETROPULSION DEVICES MARKET TRENDS & INSIGHTS

12 DEMAND AND SUPPLY SIDE ANALYSIS

  • 12.1. Demand Side Analysis
  • 12.2. Supply Side Analysis

13 VALUE CHAIN ANALYSIS

14 PRICING ANALYSIS

15 COMPETITIVE SCENARIO

  • 15.1. Competitive Landscape
    • 15.1.1 Porter's Five forces analysis

16 COMPANY PROFILED

  • 16.1. Accordion Medical
  • 16.2. AstraZeneca pharma
  • 16.3. Boston Scientific Corporation
  • 16.4. Cook
  • 16.5. Teleflex Incorporated
  • 16.6. NIKSAN PHARMACEUTICAL
  • 16.7. AdvaCare Pharma
  • 16.8. Omicron Pharma
  • 16.9. Cadila Pharmaceutical
  • 16.10. ORFE MEDICAL

17 DISCLAIMER